Department of Addictology, Saint-Eloi Hospital, CHRU Montpellier, Montpellier, France.
INSERM, U1183, IRMB, Saint-Eloi Hospital, CHRU Montpellier, Montpellier, France.
Alcohol Clin Exp Res. 2018 Jan;42(1):32-40. doi: 10.1111/acer.13527. Epub 2017 Nov 22.
The human intestinal microbiota exerts beneficial or harmful effects in several disorders. Many factors, including alcohol consumption, may influence its composition and trigger bacterial translocation. Excessive alcohol consumption increases gut permeability and translocation of endotoxin into peripheral circulation. Although plasma endotoxin concentrations have been measured often, quantitative changes following alcohol withdrawal have never been described in subjects with alcohol use disorder (AUD). The aim of this study was to measure microbial translocation (MT) and gut permeability markers in patients with AUD, to compare these markers to healthy controls (HC) and to monitor markers during the first 6 weeks of abstinence.
Sixty-five patients with AUD and hospitalized for alcohol withdrawal were included. Epidemiological, clinical, biological, and addictological data were gathered. Blood samples were collected at baseline, then 3 and 6 weeks after alcohol withdrawal. A hundred healthy volunteers were used as controls. Three markers of MT were monitored in plasma samples: sCD14 and lipopolysaccharide-binding protein (LBP) were quantified using ELISA, and 16S rDNA was quantified using real-time polymerase chain reaction. Zonulin and intestinal fatty acid binding protein (I-FABP) blood levels were also monitored as indirect markers of gut permeability, using ELISA.
At baseline, LBP, 16S rDNA, sCD14 and I-FABP markers were significantly higher in patients with AUD than in HC. Six weeks after alcohol withdrawal plasma levels of sCD14 and LBP decreased significantly. Cannabis consumption and body mass index (BMI) before alcohol withdrawal influenced baseline MT levels and the decrease in MT markers after 6 weeks. Finally, markers of MT and gut permeability did not correlate with each other before and after alcohol withdrawal.
Before alcohol withdrawal, MT markers were higher in patients with AUD than in HC. After 6 weeks of abstinence, an improvement in MT markers was observed. Our data suggest that there is a link between MT, its improvement, BMI, and cannabis consumption.
人类肠道微生物群在多种疾病中产生有益或有害的影响。许多因素,包括饮酒,可能会影响其组成并引发细菌易位。过量饮酒会增加肠道通透性并将内毒素转移到外周循环中。尽管经常测量血浆内毒素浓度,但从未在酒精使用障碍(AUD)患者中描述过酒精戒断后的定量变化。本研究旨在测量 AUD 患者的微生物易位(MT)和肠道通透性标志物,将这些标志物与健康对照(HC)进行比较,并在酒精戒断后的前 6 周监测标志物。
共纳入 65 例 AUD 患者,并因酒精戒断住院。收集了流行病学、临床、生物学和成瘾学数据。在基线、酒精戒断后 3 周和 6 周采集血样。使用 100 名健康志愿者作为对照。监测血浆样本中的 3 种 MT 标志物:使用 ELISA 定量检测 sCD14 和脂多糖结合蛋白(LBP),使用实时聚合酶链反应定量检测 16S rDNA。还使用 ELISA 监测血中肠屏障通透性的间接标志物:紧密连接蛋白(zonulin)和肠脂肪酸结合蛋白(I-FABP)。
在基线时,AUD 患者的 LBP、16S rDNA、sCD14 和 I-FABP 标志物明显高于 HC。酒精戒断 6 周后,sCD14 和 LBP 血浆水平显著降低。酒精戒断前的大麻摄入和体重指数(BMI)影响 MT 标志物的基线水平和 6 周后的 MT 标志物降低。最后,酒精戒断前后 MT 和肠通透性标志物之间没有相关性。
在酒精戒断前,AUD 患者的 MT 标志物高于 HC。在 6 周的戒断后,MT 标志物有所改善。我们的数据表明,MT、其改善、BMI 和大麻摄入之间存在关联。